Heart transplantation

Minerva Chirurgica

Volumn 64, Issue 1, 2009, Pages 23-35

  Yun, J J ^a   Gonzalez Stawinski, G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac surgical procedures; Heart diseases, surgery; Heart transplantation

Indexed keywords

EID: 67650260661     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Carrel A, Guthrie CC. The transplantation of veins and organs. Am Med 1905;10:1101-2.
2. Mann FC, Priestley JT, Markowitz J, Yater WM. Transplantation of the intact mammalian heart. Arch Surg 1933;26:219-24.
3. Demikhov VP. Experimental Transplantation of vital organs. New York: Consultant's Bureau; 1962.
4. Neptune WB, Cookson BA, Bailey CP, Appier R, Rajkowski F. Complete homologous heart transplantation. Am Med Assoc Arch Surg 1953;66:174-8.
5. Webb WR, Howard HS. Restoration of function of the refrigerated heart. Surg Forum 1957;8:302-6.
6. Cass MH, Brock R. Heart excision and replacement. Guy's Hosp Reps 1959;108:285-90.
7. Lower R, Shumway NE. Studies on orthotopic homo-transplantation of the canine heart. Surg Forum 1960;11:18.
8. Hardy JD, Chavez CM, Kurrus FD, Neely WA, Eraslan S, Turner D el al. Heart transplantation in man. JAMA 1964;188:114-22.
9. Barnard CN. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Capetown. S Afr J Med 1967;41:1271-4.
10. Kantrowitz A, Huller JD, Joos H, Cerroti MM, Carstensen HE. Transplantation of the heart in an ifant and an adult. Am J Cardiol 1968;22:782-90.
11. Lansman S, Ergin MA, Griepp RB. History of cardiac transplantation. In: Wallwork J. Heart and Heart-Lung Transplantation. Philadelphia: WB Saunders Co.; 1989.
12. Kahan B. Cyclosporine: the agent and its actions. Transplant Proc 1985;17:5-18.
13. Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982;306:557-64.
14. Taylor DO, Edwards LB, Aurora P, Christie J, Dobbels F, Kirk R et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant 2008;27:943-56.
15. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA Parameshwar J et al. Listing criteria for heart transplantation: International society for heart and lung transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 2006:25: 1024-42.
16. Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001;38: 923-31.
17. Butler J, Stankewicz MA, Wu J, Chomsky DB, Hawser RL, Khadim G et al. Pretransplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant 2005;24:170-7.
18. Costard-Jackie A Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992; 19:48-54.
19. Indications, contraindications, and differential therapeutic alternatives in heart transplantation. Current status and results of a survey by the German Transplantation Programs. Thoracic Organ Transplantation Study Group of the German Society of Cardiology-Heart and Lung Research. Z Kardiol 1996; 85:519-27.
20. Erdoes LS, Hunter GC, Venerus BJ, Hall KA, Bull DA, Berman SS et al. Prospective evaluation of peripheral vascular disease in heart transplant recipients. J Vasc Surg 1995;22:434-40.
21. http://organdonor.gov
22. Chen JM, Russo MJ, Hammond KM, Mancini D, Kherani AR, Fai J et al. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg 2005;80:224-8.
23. Lima B, Rajagopal K, Petersen R, Shah A, Soule B, Felker GM et al. Marginal cardiac allografts do not have increased primary graft dysfunction on alternate list transplantation. Circulation 2006;114:I-27-32.
24. Patel J, Kobashigawa J. Cardiac transplantation: the alternate list and expansion of the donor pool. Curr Opin Cardiol 2004;19:162-5.
25. Marelli D, Laks H, Fazio D, Moore S, Moriguchi J, Kobashigawa J. The use of hearts with left ventricular hypertrophy. J Heart Lung Transplant 2000;19:496-503.
26. Gudmundsson GS, Malinowska K, Robinson JA, Pisani BA, Mendez JC, Foy BK et al. Five-year follow up of hepatitis C naïve heart transplant recipients who received hepatitis C positive hearts. Transplant Proc 2003; 35:1536-8.
27. Marelli D, Laks H, Bresson S, Ardehali A, Bresson J, Esmailian F et al. Results after transplantation using donor hearts with preexisting coronary artery disease. J Thorac Cardiovasc Surg 2003;126:821-5.
28. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the "unacceptable" donor. J Heart Lung Transplant 1995;14:734-42.
29. Novitsky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead donor. Transplantation 2006;82:1396-401.
30. Pennington DG, Merjavy J, Codd J, Swartz M, Miller L, Williams GA. Extracorporeal membrane oxygenation for patients with cardiogenic shock. Circulation 1984;70 (Suppl I):130-7.
31. Pennington DG. Circulatory support before transplantation. In: Wallwork J. Heart and Heart-Lung Transplantaion. Philadelphia: WB Saunders and Co.; 1989.
32. Rose EA, Gelijns A, Moscowitz A, Heitjan D, Stevenson L, Dembitsky W et al. Long-term mechanical left ventricular siistance for end-stage heart failure. N Engl J Med 2001;345:1435-43.
33. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008;86:1227-34.
34. Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008;359:242-51.
35. Novitsky D, Cooper C, Baraard C. The surgical technique of heterotopic heart transplantation. Ann Thor Surg 1983;36:476-82.
36. Fink J, Buda T, Hartman D, et al. The Cleveland Clinic Heart Transplant Manual for Adults. In press.
37. Mastrobuoni M, Ubilla M, Cordero A, Herreros J, Rabago G. Two-dose daclizumab, tacrolimus, mycophenolate mofetil, and steroid-free regimen in de novo cardiac transplant recipients: early experience. Transplant Proc 2007;39:2163-6.
38. Schmauss D, Weis M. Cardiac allograft vasculopathy. Circulation 2008;117:2131-41.
39. Belperio J, Ardehali A. Chemokines and transplant vasculopathy. Circ Res 2008;103:454-66.
40. Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D et al. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation 2004;172:7417-24.
41. Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003;108:48-53.
42. Kobashigawa J, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM et al. Effect of pravastatin on outcomes after cardiac transplantation. N Eng J Med 1995;333:621-7.
43. Tjang YS, Tenderich G, Hornik L, Korfer R. Cardiac retransplantation in adults: an evidence-based systematic review. Thorac Cardiov Surg 2008;56:323-37.
44. Johnson MR, Aaronson KD, Canter CE, Kirklin JK, Mancini DM, Mehra MR et al. Heart retransplantation. Am J Transplant 2007;7:2075-81.
45. Fonarow GC. How old is too old for heart transplantation? Curr Opin Cardiol 2000;15:97-103.
46. Marelli D, Kobashigawa J, Hamilton M, Moriguchi J, Kermani R, Ardehali A et al. Long-term outcomes of heart transplantation in older recipients. J Heart Lung Transplant 2008;27:830-4.
47. Tenderich G, El-Banayosy, A, Rosengard B, Tsui S, Wallwork J, Hetzer R et al. Prospective multi-center European trial to evaluate the safety and performance of the organ care system for heart transplants (PROTECT). J Heart Lung Transplant 2007;26:S64.
48. Howards RJ, Schold JD, Cornell DL. A 10 year analysis of organ donation after cardiac death in the United States. Transplantation 2005;80:569-70.
49. Boucek MM, Mashburn C, Dunn SM, Frizell R, Edwards L, Pietra B et al. Pediatric heart transplantation after declaration of cardiocirculatory death. N Eng J Med 2008;359:709-14.
50. Ekser B, Rigotti O, Gridelli B, Cooper DK. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol 2008;19:25.
51. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004;4:1383-90.